We are live on ! Find out more
AMTX icon

Aemetis

74 hedge funds and large institutions have $23.5M invested in Aemetis in 2025 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 29 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

4% more funds holding

Funds holding: 7174 (+3)

4% less capital invested

Capital invested by funds: $24.6M → $23.5M (-$1.09M)

1.4% less ownership

Funds ownership: 17.88%16.48% (-1.4%)

41% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 29

43% less call options, than puts

Call options by funds: $876K | Put options by funds: $1.53M

Holders
74
Holders Change
+3
Holders Change %
+4.23%
% of All Funds
0.97%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
17
Reduced
29
Closed
9
Calls
$876K
Puts
$1.53M
Net Calls
-$650K
Net Calls Change
+$47K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$5.58M +$875K +329,760 +15%
Grantham, Mayo, Van Otterloo & Co (GMO)
2
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$2.28M -$1.73M -652,100 -39%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$1.74M +$1.21M +454,514 +142%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.49M +$256K +96,364 +17%
BlackRock
5
BlackRock
New York
$1.35M -$18.1K -6,809 -1%
Millennium Management
6
Millennium Management
New York
$1.19M -$45.2K -17,020 -3%
Goldman Sachs
7
Goldman Sachs
New York
$971K -$299K -112,494 -21%
Renaissance Technologies
8
Renaissance Technologies
New York
$817K +$964K +363,001 New
Citadel Advisors
9
Citadel Advisors
Florida
$752K +$206K +77,443 +30%
CIBC Private Wealth Group
10
CIBC Private Wealth Group
Georgia
$563K
State Street
11
State Street
Massachusetts
$514K -$289K -108,700 -32%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$450K +$531K +199,907 New
GCP
13
GSA Capital Partners
United Kingdom
$405K +$142K +53,508 +42%
Two Sigma Investments
14
Two Sigma Investments
New York
$360K -$151K -57,023 -26%
Marshall Wace
15
Marshall Wace
United Kingdom
$323K +$382K +143,776 New
LPL Financial
16
LPL Financial
California
$294K +$17.3K +6,500 +5%
UBS Group
17
UBS Group
Switzerland
$253K +$125K +47,231 +72%
Stifel Financial
18
Stifel Financial
Missouri
$253K -$21K -7,900 -7%
Northern Trust
19
Northern Trust
Illinois
$232K -$1.33K -500 -0.5%
PNC Financial Services Group
20
PNC Financial Services Group
Pennsylvania
$230K -$4.5K -1,697 -2%
BCM
21
Bridgeway Capital Management
Texas
$229K +$133K +50,000 +96%
Simplex Trading
22
Simplex Trading
Illinois
$217K -$5.93K -2,234 -2%
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$216K +$26.3K +9,891 +12%
Jane Street
24
Jane Street
New York
$208K -$433K -163,084 -64%
Morgan Stanley
25
Morgan Stanley
New York
$206K -$55K -20,719 -18%

AMTX Hedge Fund Activity: Q3 2025 in Review

74 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Aemetis (AMTX) for Q3 2025, worth a combined $23.5M — down 4.5% from $24.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new AMTX positions and 9 closed out — a net gain of 3 holders — while 17 added to existing stakes and 29 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $1.21M. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $1.73M.

  • 74 institutional investors held Aemetis (AMTX) as of Q3 2025, up from 71 in Q2 2025.
  • Funds reported $23.5M of Aemetis stock for Q3 2025, down 4.5% quarter-over-quarter.
  • 12 funds opened new Aemetis positions in Q3 2025 and 9 closed out, a net change of +3 holders.
  • The largest Aemetis buyer in Q3 2025 was Susquehanna International Group, an estimated $1.21M added.
  • The largest Aemetis seller in Q3 2025 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $1.73M sold.

Based on aggregated 13F filings for Q3 2025.